` Comparison: 2162, ABBV - Alpha Spread

K
2162
vs
ABBV

Over the past 12 months, KeyMed Biosciences Inc has significantly outperformed ABBV, delivering a return of +36% compared to the ABBV's +9% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
2162
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

KeyMed Biosciences Inc Intrinsic Value
HIDDEN
Show
ABBV Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
K
KeyMed Biosciences Inc
HKEX:2162
60.25 HKD
Abbvie Inc
NYSE:ABBV
218.04 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
2162, ABBV

2162
ABBV
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
K
KeyMed Biosciences Inc
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
2162, ABBV

2162
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
K
KeyMed Biosciences Inc
HKEX:2162
Abbvie Inc
NYSE:ABBV
What is Free Cash Flow?

Gross Margin

KeyMed Biosciences Inc
95.2%
ABBV
70.9%
LTM 3Y Avg 5Y Avg 10Y Avg
K
KeyMed Biosciences Inc
Abbvie Inc

Operating Margin

KeyMed Biosciences Inc
-33.2%
ABBV
31.3%
LTM 3Y Avg 5Y Avg 10Y Avg
K
KeyMed Biosciences Inc
Abbvie Inc

Net Margin

KeyMed Biosciences Inc
-29.5%
ABBV
6.4%
LTM 3Y Avg 5Y Avg 10Y Avg
K
KeyMed Biosciences Inc
Abbvie Inc

FCF Margin

KeyMed Biosciences Inc
-115.1%
ABBV
31.3%
LTM 3Y Avg 5Y Avg 10Y Avg
K
KeyMed Biosciences Inc
Abbvie Inc

ROE

KeyMed Biosciences Inc
-8.8%
ABBV
112.9%
LTM 3Y Avg 5Y Avg 10Y Avg
K
KeyMed Biosciences Inc
Abbvie Inc

ROA

KeyMed Biosciences Inc
-6.1%
ABBV
2.7%
LTM 3Y Avg 5Y Avg 10Y Avg
K
KeyMed Biosciences Inc
Abbvie Inc

ROIC

KeyMed Biosciences Inc
-19.6%
ABBV
22.9%
LTM 3Y Avg 5Y Avg 10Y Avg
K
KeyMed Biosciences Inc
Abbvie Inc

ROCE

KeyMed Biosciences Inc
-8.2%
ABBV
18.5%
LTM 3Y Avg 5Y Avg 10Y Avg
K
KeyMed Biosciences Inc
Abbvie Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
2162, ABBV

Loading

Performance Gap
2162, ABBV

Performance Gap Between 2162 and ABBV
HIDDEN
Show

Performance By Year
2162, ABBV

Loading
2162
ABBV
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 2162 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account